Covid-19 Pills
- All
- News
- Videos
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
New York City To Deliver Free Antiviral Pills To Covid Patients
New York City will provide free antiviral pills, home-delivered, to people who test positive and are at higher risk from Covid-19, Mayor Eric Adams announced on Sunday.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
Sensex, Nifty Trade Edge Higher As Pharma Stocks Lead Rise
Sensex, Nifty Updates: The Nifty pharma index was the top gainer, rising 0.9 per cent a day after India approved Merck's COVID-19 pill and two more vaccines for emergency use.
-
Anti-Covid Pill Cleared, But Will India Place Bulk Orders?
The next big breakthrough in the fight against COVID-19 is here and India has a chance to be among the first nations to manufacture billions of doses of a series of new anti-viral pills.
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
New York City To Deliver Free Antiviral Pills To Covid Patients
New York City will provide free antiviral pills, home-delivered, to people who test positive and are at higher risk from Covid-19, Mayor Eric Adams announced on Sunday.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
Sensex, Nifty Trade Edge Higher As Pharma Stocks Lead Rise
Sensex, Nifty Updates: The Nifty pharma index was the top gainer, rising 0.9 per cent a day after India approved Merck's COVID-19 pill and two more vaccines for emergency use.
-
Anti-Covid Pill Cleared, But Will India Place Bulk Orders?
The next big breakthrough in the fight against COVID-19 is here and India has a chance to be among the first nations to manufacture billions of doses of a series of new anti-viral pills.
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
